Salk scientists develop new technique to heal large ulcers by reprogramming wound cells into skin cells
Plastic surgery to treat large cutaneous ulcers, including those seen in people with severe burns, bedsores or chronic diseases such as diabetes, may someday be a thing of the past. Scientists at the Salk Institute have developed a technique to directly convert the cells in an open wound into new skin cells. The approach relies on reprogramming the cells to a stem-cell-like state and could be useful for healing skin damage, countering the effects of aging and helping us to better understand skin cancer.
“Our observations constitute an initial proof of principle for in vivo regeneration of an entire three-dimensional tissue like the skin, not just individual cell types as previously shown,” says Salk Professor Juan Carlos Izpisua Belmonte, holder of the Roger Guillemin Chair and senior author of the new paper, published in the journal Nature on September 5, 2018. “This knowledge might not only be useful for enhancing skin repair but could also serve to guide in vivo regenerative strategies in other human pathological situations, as well as during aging, in which tissue repair is impaired.”
Cutaneous ulcers—wounds that can extend through multiple layers of the skin—are typically treated surgically, by transplanting existing skin to cover the wound. However, when the ulcer is especially large, it can be difficult for surgeons to graft enough skin. In these cases, researchers are able to isolate skin stem cells from a patient, grow them in the lab and transplant them back into the patient. However, such a procedure requires an extensive amount of time, which may put the patient’s life at risk and is sometimes not effective.
Izpisua Belmonte and Salk Research Associate Masakazu Kurita, who has a background in plastic surgery, knew that a critical step in wound recovery was the migration—or transplantation—of basal keratinocytes into wounds. These stem-cell-like cells act as precursors to the different types of skin cells. But large, severe wounds that have lost multiple layers of skin no longer have any basal keratinocytes. And even as these wounds heal, the cells multiplying in the area are mainly involved in wound closure and inflammation, rather than rebuilding healthy skin.
Izpisua Belmonte and Kurita wanted to directly convert these other cells into basal keratinocytes—without ever taking them out of the body. “We set out to make skin where there was no skin to start with,” says Kurita.
The researchers first compared the levels of different proteins of the two cell types (inflammation and keratinocytes) to get a sense of what they’d need to change to reprogram the cells’ identities. They pinpointed 55 “reprogramming factors” (proteins and RNA molecules) that were potentially involved in defining the distinct identity of the basal keratinocytes. Then, through trial and error and further experiments on each potential reprogramming factor, they narrowed the list down to four factors that could mediate the conversion to basal keratinocytes.
When the team topically treated skin ulcers on mice with the four factors, the ulcers grew healthy skin (known as epithelia) within 18 days. Over time, the epithelia expanded and connected to the surrounding skin, even in large ulcers. At three and six months later, the generated cells behaved like healthy skin cells in a number of molecular, genetic and cellular tests.
The researchers are planning more studies to optimize the technique and begin testing it in additional ulcer models.
“Before going to the clinic, we have to do more studies on the long-term safety of our approach and enhance the efficiency as much as possible,” says Kurita.
The Latest on: Reprogramming cells
via Google News
The Latest on: Reprogramming cells
- Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming on February 20, 2019 at 2:29 am
Direct cardiac reprogramming converts fibroblasts into cardiomyocyte-like cells (iCMs), without passing through a stem cell state, by the overexpression of cardiac transcription factors including Gata... […]
- Darrin Disley takes CEO role at cell therapy startup on February 20, 2019 at 1:30 am
Cell Mogrify has named ex-Horizon Discovery CEO Darrin Disley as its leader. Disley joined Mogrify and participated in its seed round to advance technology for direct reprogramming between mature cell ... […]
- CRISPR Gene Editing Makes Stem Cells ‘Invisible’ to Immune System on February 19, 2019 at 6:06 am
... by induced pluripotent stem cells (iPSCs), which are created from fully-mature cells — like skin or fat cells — that are reprogrammed in ways that allow them to develop into any of the myriad cell... […]
- CRISPR Drapes Invisibility Cloak over Stem Cells on February 19, 2019 at 5:40 am
iPSCs are a type of stem cell generated by reprogramming mature cells such as skin or fat cells into an undifferentiated state. These undifferentiated cells can then be grown in the laboratory and tri... […]
- Japan approves test of iPS cells for treating spinal injuries on February 18, 2019 at 5:47 am
So-called iPS cells are made by removing mature cells from an individual - often from the skin - and reprogramming them to behave like embryonic stem cells. Last year, clinical trials began in Japan o... […]
- Mayo Clinic finds better way to reprogram stem cells on February 17, 2019 at 11:15 pm
Induced pluripotent stem cells, which are used in many regenerative medicine projects, are now easier to make. That’s good news for researchers developing regenerative therapies, according to the Mayo ... […]
- Reprogramming pancreatic cells into insulin makers to treat diabetes on February 14, 2019 at 10:42 am
Diabetes occurs when the insulin-producing beta cells of the pancreas are destroyed or become dysfunctional. Scientists are keen to find methods for regenerating these cells to treat diabetes. Now, re... […]
- Human cells reprogrammed to create insulin on February 13, 2019 at 10:32 am
The destruction of a single kind of insulin-producing cell in the pancreas can lead to diabetes — but a study suggests that other cells could be modified to take its place and help to control blood su... […]
- Reprogrammed Human Pancreatic Cells Treat Diabetes in Mice on February 13, 2019 at 10:00 am
Nearly 10 percent of Americans have diabetes, a chronic condition where the body does not process sugar. Diabetics either do not make enough insulin — a hormone that acts like a key to let ... […]
- More efficient system to reprogram stem cells on February 12, 2019 at 10:51 am
Induced pluripotent stem cells, the workhorse of many regenerative medicine projects, start out as differentiated cells that are reprogrammed to pluripotent stem cells by exposure to a complex set of ... […]
via Bing News